Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00025764
DRKS00025764
Completed
未知

A multi-national multicenter feasibility study of Integrated Care Networks in Parkinson disease: a patientcentered integrated care delivery model in Parkinson disease - iCARE-PD

The Ottawa Hospital Research Institute/University of Ottawa and University of Ottawa Brain and Mind Research Institute0 sites32 target enrollmentJuly 16, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsG20Parkinson disease

Overview

Phase
未知
Intervention
Not specified
Conditions
G20
Sponsor
The Ottawa Hospital Research Institute/University of Ottawa and University of Ottawa Brain and Mind Research Institute
Enrollment
32
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 16, 2021
End Date
December 31, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Ottawa Hospital Research Institute/University of Ottawa and University of Ottawa Brain and Mind Research Institute

Eligibility Criteria

Inclusion Criteria

  • •The iCARE\-PD care model is open to all Parkinson's patients and their care partners, taking into account the exclusion criteria. The age of the patients and their caregivers does not matter, as does the gender or origin of the patients and their relatives.

Exclusion Criteria

  • •Patients who meet one or more of the following criteria will be excluded from the study:
  • •1\. Patients who are unable to give consent
  • •2\. Patients who are in\-patient care in a nursing home
  • •3\. Patients whose autonomy is restricted due to motor symptoms (Hoehn \& Yahr \= 5\)
  • •4\. Patients who are restricted in their autonomy due to significant dementia diagnosed by a doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
CRYOSTAT study: To determine whether early administration of cryoprecipitate in bleeding trauma patients is possible.
ISRCTN55509212HS Blood and Transplant Service (UK)40
Recruiting
Not Applicable
MesoCyto Study
JPRN-UMIN000038709Hyogo College of Medicine100
Completed
Not Applicable
A Multi-Center Feasibility Study Evaluating the Osprey Medical Contrast (dye injected into coronary blood vessels) Removal System during diagnostic or interventional percutaneous coronary procedure - in order to prevent contrast induced nephropathy.Contrast-induced nephropathyRenal and Urogenital - Kidney disease
ACTRN12608000135314Osprey Medical Pty Ltd40
Terminated
Phase 2
Feasibility study of normoxic versus hyperoxic therapy after cardiac arrestCardiovascular - Other cardiovascular diseasesOut-of-hospital cardiac arrest
ACTRN12612001054808Medical Research Institute of New Zealand42
Completed
Not Applicable
CONSERVE study
ISRCTN23852951ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)74